Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1686-1696

  Gerard, Brigitte ^a,d   Sanders, Matthew A ^b   Visscher, Daniel W ^c   Tait, Larry ^b   Shekhar, Malathy P V ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d Everist Genomics   (United States)

Author keywords

Breast cancer; Transcriptional activity; Ubiquitination; Wnt signaling

Indexed keywords

AMINO ACID; ARGININE; ARMADILLO DOMAIN PROTEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA CATENIN; LYSINE; T CELL FACTOR PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME RAD6B; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BREAST CARCINOMA; BREAST RECONSTRUCTION; CONTROLLED STUDY; DELETION MUTANT; HUMAN; HUMAN CELL; LYMPH NODE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; UBIQUITINATION; UPREGULATION;

ARMADILLO DOMAIN PROTEINS; BETA CATENIN; BREAST NEOPLASMS; CATALYTIC DOMAIN; CELL LINE, TUMOR; FEMALE; GENE SILENCING; HUMANS; LYSINE; MUTATION; NEOPLASM INVASIVENESS; PROTEIN BINDING; TRANSCRIPTION, GENETIC; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINATION; UP-REGULATION;

ARMADILLO;

EID: 84864749507     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.05.032     Document Type: Article

References (48)

1. Jentsch S., McGrath J.P., Varshavsky A. The yeast DNA repair gene RAD6 encodes a ubiquitin-conjugating enzyme. Nature 1987, 329:131-134.
2. Lawrence C. The RAD6 DNA repair pathway in Saccharomyces cerevisiae: what does it do, and how does it do it?. Bioessays 1994, 16:253-258.
3. Reynolds P., Weber S., Prakash L. RAD6 gene of Saccharomyces cerevisiae encodes a protein containing a tract of 13 consecutive aspartates. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:168-172.
4. Sung P., Prakash S., Prakash L. Mutation of cysteine-88 in the Saccharomyces cerevisiae RAD6 protein abolishes its ubiquitin-conjugating activity and its various biological functions. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2695-2699.
5. Sung P., Prakash S., Prakash L. Stable ester conjugate between the Saccharomyces cerevisiae RAD6 protein and ubiquitin has no biological activity. J. Mol. Biol. 1991, 221:745-749.
6. Koken M.H., Reynolds P., Jaspers-Dekker I., Prakash L., Prakash S., Bootsma D., Hoeijmakers J.H. Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:8865-8869.
7. Koken M.H., Smit E.M., Jaspers-Dekker I., Oostra B.A., Hagemeijer A., Bootsma D., Hoeijmakers J.H. Localization of two human homologs, HHR6A and HHR6B, of the yeast DNA repair gene RAD6 to chromosomes Xq24-q25 and 5q23-q31. Genomics 1992, 12:447-453.
8. Shekhar M.P., Lyakhovich A., Visscher D.W., Heng H., Kondrat N. Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation. Cancer Res. 2002, 62:2115-2124.
9. Shekhar M.P., Gerard B., Pauley R.J., Williams B.O., Tait L. Rad6B is a positive regulator of beta-catenin stabilization. Cancer Res. 2008, 68:1741-1750.
10. Shekhar M.P., Tait L., Gerard B. Essential role of T-cell factor/beta-catenin in regulation of Rad6B: a potential mechanism for Rad6B overexpression in breast cancer cells. Mol. Cancer Res. 2006, 4:729-745.
11. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
12. Dierick H., Bejsovec A. Cellular mechanisms of wingless/Wnt signal transduction. Curr. Top. Dev. Biol. 1999, 43:153-190.
13. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
14. Seidensticker M.J., Behrens J. Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta 2000, 1495:168-182.
15. Wagenaar R.A., Crawford H.C., Matrisian L.M. Stabilized beta-catenin immortalizes colonic epithelial cells. Cancer Res. 2001, 61:2097-2104.
16. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997, 11:3286-3305.
17. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
18. Kitagawa M., Hatakeyama S., Shirane M., Matsumoto M., Ishida N., Hattori K., Nakamichi I., Kikuchi A., Nakayama K. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J. 1999, 18:2401-2410.
19. Brennan K.R., Brown A.M. Wnt proteins in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 2004, 9:119-131.
20. Brown A.M. Wnt signaling in breast cancer: have we come full circle?. Breast Cancer Res. 2001, 3:351-355.
21. Howe L.R., Brown A.M. Wnt signaling and breast cancer. Cancer Biol. Ther. 2004, 3:36-41.
22. Candidus S., Bischoff P., Becker K.F., Hofler H. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res. 1996, 56:49-52.
23. Shekhar M.P., Santner S., Carolin K.A., Tait L. Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am. J. Pathol. 2007, 170:1546-1560.
24. Brennan K., Gonzalez-Sancho J.M., Castelo-Soccio L.A., Howe L.R., Brown A.M. Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins. Oncogene 2004, 23:4873-4884.
25. Gerard B., Tait L., Nangia-Makker P., Shekhar M.P. Rad6B acts downstream of Wnt signaling to stabilize beta-catenin: implications for a novel Wnt/beta-catenin target. J. Mol. Signal. 2011, 6:6.
26. Taylor-Papadimitriou J., Stampfer M., Bartek J., Lewis A., Boshell M., Lane E.B., Leigh I.M. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J. Cell Sci. 1989, 94(Pt 3):403-413.
27. Treier M., Staszewski L.M., Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 1994, 78:787-798.
28. Genander M., Halford M.M., Xu N.J., Eriksson M., Yu Z., Qiu Z., Martling A., Greicius G., Thakar S., Catchpole T., Chumley M.J., Zdunek S., Wang C., Holm T., Goff S.P., Pettersson S., Pestell R.G., Henkemeyer M., Frisen J. Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell 2009, 139:679-692.
29. Yeh E., Cunningham M., Arnold H., Chasse D., Monteith T., Ivaldi G., Hahn W.C., Stukenberg P.T., Shenolikar S., Uchida T., Counter C.M., Nevins J.R., Means A.R., Sears R. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 2004, 6:308-318.
30. Dolled-Filhart M., McCabe A., Giltnane J., Cregger M., Camp R.L., Rimm D.L. Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res. 2006, 66:5487-5494.
31. Choi H.J., Huber A.H., Weis W.I. Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity. J. Biol. Chem. 2006, 281:1027-1038.
32. Woelfle U., Sauter G., Santjer S., Brakenhoff R., Pantel K. Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clin. Cancer Res. 2004, 10:2670-2674.
33. Robzyk K., Recht J., Osley M.A. Rad6-dependent ubiquitination of histone H2B in yeast. Science 2000, 287:501-504.
34. Sung P., Prakash S., Prakash L. The RAD6 protein of Saccharomyces cerevisiae polyubiquitinates histones, and its acidic domain mediates this activity. Genes Dev. 1988, 2:1476-1485.
35. Amit S., Hatzubai A., Birman Y., Andersen J.S., Ben-Shushan E., Mann M., Ben-Neriah Y., Alkalay I. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002, 16:1066-1076.
36. Bustos V.H., Ferrarese A., Venerando A., Marin O., Allende J.E., Pinna L.A. The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19725-19730.
37. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
38. Orford K., Crockett C., Jensen J.P., Weissman A.M., Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J. Biol. Chem. 1997, 272:24735-24738.
39. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997, 16:3797-3804.
40. Winer I.S., Bommer G.T., Gonik N., Fearon E.R. Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation. J. Biol. Chem. 2006, 281:26181-26187.
41. Radivojac P., Vacic V., Haynes C., Cocklin R.R., Mohan A., Heyen J.W., Goebl M.G., Iakoucheva L.M. Identification, analysis, and prediction of protein ubiquitination sites. Proteins 2010, 78:365-380.
42. von Kries J.P., Winbeck G., Asbrand C., Schwarz-Romond T., Sochnikova N., Dell'Oro A., Behrens J., Birchmeier W. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat. Struct. Biol. 2000, 7:800-807.
43. Levy L., Wei Y., Labalette C., Wu Y., Renard C.A., Buendia M.A., Neuveut C. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol. 2004, 24:3404-3414.
44. Rowlands T.M., Pechenkina I.V., Hatsell S.J., Pestell R.G., Cowin P. Dissecting the roles of beta-catenin and cyclin D1 during mammary development and neoplasia. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11400-11405.
45. Lin S.Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., Hung M.C. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4262-4266.
46. Clapper M.L., Coudry J., Chang W.C. Beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention. Mutat. Res. 2004, 555:97-105.
47. Dihlmann S., von Knebel Doeberitz M. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int. J. Cancer 2005, 113:515-524.
48. Dvory-Sobol H., Sagiv E., Kazanov D., Ben-Ze'ev A., Arber N. Targeting the active beta-catenin pathway to treat cancer cells. Mol. Cancer Ther. 2006, 5:2861-2871.